Trials / Terminated
TerminatedNCT00642083
Stenting of Haemodialysis Acces Trial
Stenting of Haemodialysis Acces Re-stenosis Trial (SHARE Trial)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rijnstate Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the efficacy of a PTFE covered stent-graft in the prevention of outflow re-stenosis in loop fistula in a prospective trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Viabahn stent-graft | The viabahn stent-graft is a combined ePTFE-Nitinol self-expanding stent-graft preloaded on a catheter-based delivery system. It was originally designed for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.8 to 7.5 mm. This device is also increasingly used for the exclusion of popliteal aneurysms. Its flexibility might make the device ideal for the treatment of recurrent outflow stenosis in AV loop-fistula. |
Timeline
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2008-03-24
- Last updated
- 2011-12-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00642083. Inclusion in this directory is not an endorsement.